DNMR
Danimer Scientific, Inc.
Set alert
0.35 USD 0.00 0.00%
0.325 Day range 1.13
2.45 52-week range 73.60
- YTD
- -83.33%
- 1 year
- -91.53%
- Open
- 0.35
- Prev close
- 0.35
- Mkt cap
- 11.51M
- Vol
- 128.42K
- Avg vol
- 64.37K
- EPS
- -40.40
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.325
- High
- 1.13
- Forward P/E
- -8.11
- Beta
- 1.63
- Short ratio
- 33.63
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 9.50
- 200-d avg
- 22.42
- 1y target
- 4.67
Key statistics
- Market cap
- 11.51M
- Enterprise value
- 402.97M
- Trailing P/E
- 0.00
- Forward P/E
- -8.11
- PEG ratio
- 0.00
- Price / sales
- 0.29
- Price / book
- 0.04
- EPS (TTM)
- -40.40
- Beta
- 1.63
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 39.74M
- Revenue growth
- -40.70%
- Free cash flow
- -15.76M
- Total cash
- 40.25M
- Total debt
- 419.07M
- Return on equity
- -45.90%
- Shares outstanding
- 3.02M
- Short % of float
- 18.96%
- 50-day average
- 9.50
- 200-day average
- 22.42
Analyst view
Consensus: hold
Hold
Price target (mean) 4.67 +1233.3% upside
Now 0.35
- Target (low)
- 4.00
- Target (mean)
- 4.67
- Target (high)
- 5.50
Ratings (0m) 3 0 buy · 2 hold · 1 sell
- Strong buy0
- Buy0
- Hold2
- Sell0
- Strong sell1
Next earnings
Aug 8, 2024
Expected Aug 8, 2024. Consensus EPS estimate -7.10.
Financials — quick view
DNMR Revenue — quarterly 8.63M
DNMR Net income — quarterly -21.84M
DNMR EPS — quarterly -7.20
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 19, 2024 | Sep 1, 2024 | -8.00 | -0.24 | +7.76 | +97.00% |
| Aug 8, 2024 | Jun 1, 2024 | -9.60 | -7.20 | +2.40 | +25.00% |
| Aug 8, 2024 | Jun 1, 2024 | -9.60 | — | — | — |
| May 7, 2024 | Mar 1, 2024 | -12.00 | -10.40 | +1.60 | +13.33% |
| May 7, 2024 | Mar 1, 2024 | -12.00 | — | — | — |
| Mar 28, 2024 | Dec 1, 2023 | -15.60 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 21, 2024 | Piper Sandler | main | Neutral | Neutral |
| Aug 13, 2024 | TD Cowen | down | Buy | Hold |
| May 22, 2024 | Jefferies | down | Buy | Hold |
| Apr 9, 2024 | Piper Sandler | down | Overweight | Neutral |
| Apr 4, 2024 | TD Cowen | main | Buy | Buy |
| Oct 11, 2023 | Piper Sandler | main | Overweight | Overweight |
About Danimer Scientific, Inc.
Danimer Scientific, Inc., a performance polymer company, provides bioplastic replacements for traditional petroleum-based plastics in the United States, Germany, Poland, Belgium, Austria, and internationally. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative under the Nodax brand name for applications in films, straws, cutlery, food containers, and others; polylactic acid-based resins for coating disposable paper cups; and other biopolymers. The company products are used in various applications, including additives, aqueous coatings, fibers, filaments, films, thermoforming, and injection-molded articles. It also markets its products to consumer packaging brand owners, converters, and manufacturers in the plastics industry. Danimer Scientific, Inc. was founded in 2004 and is headquartered in Bainbridge, Georgia.
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
- Country
- United States
- Website
- danimerscientific.com
News
- Danimer Scientific Announces Common Stock Expected to Begin Trading Promptly on OTCQX Marketplace
- NYSE to Commence Delisting Proceedings Against Danimer Scientific, Inc. (DNMR)
- Danimer Scientific Takes Action to Strengthen Capital Structure
- TerraNova Capital Equities announces three transactions totaling $45 Million
- Danimer Scientific, Inc. (DNMR) Q3 2024 Earnings Call Transcript
- Danimer Scientific, Inc. (DNMR) Reports Q3 Loss, Tops Revenue Estimates
- Danimer Scientific Announces Third Quarter 2024 Results
- Earnings Scheduled For November 19, 2024
- Danimer Scientific Announces Release Date for Third Quarter 2024 Results
- Earnings Scheduled For November 14, 2024
Your note
Sign in to keep a note on DNMR — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| AMBOIAN JOHN P | Director | Conversion of Exercise of derivative security | May 30, 2024 | 936,436 |
| CALHOUN PHILIP GREGORY | Director | Conversion of Exercise of derivative security | May 30, 2024 | 3,801,910 |
| COHEN CYNTHIA R. | Director | Conversion of Exercise of derivative security | May 30, 2024 | 18,272 |
| HAJOST MICHAEL A. | Chief Financial Officer | Conversion of Exercise of derivative security | Feb 6, 2024 | 71,064 |
| HENDRIX RICHARD J JR | Director | Conversion of Exercise of derivative security | May 30, 2024 | 459,596 |
| HUNT GREGORY WILLIAM | Director | Conversion of Exercise of derivative security | May 30, 2024 | 23,256 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Armistice Capital, LLC | 0.22% | 269,700 | 1.03M | Sep 29, 2024 |
| Vanguard Group Inc | 0.10% | 115,431 | 439.79K | Sep 29, 2024 |
| Invesco Ltd. | 0.04% | 48,816 | 185.99K | Sep 29, 2024 |
| Jefferies Financial Group Inc. | 0.04% | 47,982 | 182.81K | Sep 29, 2024 |
| Blackrock Inc. | 0.03% | 32,080 | 122.22K | Sep 29, 2024 |
| Millennium Management Llc | 0.03% | 34,563 | 131.69K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 0.06% | 73,111 | 278.55K | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 0.03% | 31,401 | 119.64K | Sep 29, 2024 |
| Schwab Strategic Tr-Schwab U.S. Small Cap ETF | 0.01% | 10,369 | 39.51K | Aug 30, 2024 |
| Invesco ETF Tr-Invesco FTSE RAFI US 1500 Small-Mid ETF | 0.01% | 9,305 | 35.45K | Sep 29, 2024 |
| Vanguard Materials Index Fund | 0.01% | 7,726 | 29.44K | Aug 30, 2024 |
| Fidelity Extended Market Index Fund | 0.01% | 15,206 | 57.93K | Oct 30, 2024 |